ayrshire_blue
Well-Known Member
- Joined
- 1 May 2008
- Messages
- 6,215
Firstly, the conclusions being drawn from this study is that the 502.V2 variant would render these vaccines ineffective. This is highly unlikely. It will take a large amount of genetic diversity to completely render the current vaccines useless. Why? Vaccines are polyclonal.
This study didn’t even look at the vaccines. They studied OLD blood sera from NATURAL infection. Therefore they already contained low antibody levels. Why is this an issue? Because everyone knows antibodies from natural infection with COVID are weak and wane in 2-3 months.
Please take note of where the study says that over half of the samples did neutralize due to the fact they had a more robust immune response. Hello? This is what vaccines do? Antibody counts would be sent high? Not to mention the study TOTALLY disregarded B-cells and T-cells.
How are you going to disregard our actual immune systems and their ability to make antibodies for later? Which may I remind you are DRIVEN by vaccines. They teach our bodies to make antibodies for later, not just during active infection (memory T-cells anyone). That’s immunity!
T-cells stimulate B-cells to make antibodies. Antibodies are just your first line of defense which is what is initiated when you get this vaccine. It’s our T-cells that are responsible for long-term immunity. When antibodies diminish after your initial inoculation, your T-cells-will tell your B-cells it’s time to produce more antibodies. As long as your T-cells still recognize this virus and inform your B-cells they need to produce antibodies, the vaccine is still doing its job. Antibodies being built up over and over again is nothing new or unique to this vaccine, this is how vaccines have always worked. This study does not account for this information concerning T-cell immunity AT ALL.
Thanks for this. The point he makes in no.5 I thought was really interesting. If I've read it right, it suggests that people who were severely ill in hospital produced antibodies which *do* work against this particular strain, but those who were mildly ill did not. It made me wonder though, if those who were mildly ill had memory T or B cells from a previous illness so that antibodies weren't actually ever required. If that's the case, it's extremely positive and might be the same for this new strain?
That's if I've deciphered what's been said correctly.